Literature DB >> 11774937

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection.

B Ruiz1, J Garay, P Correa, E T Fontham, J C Bravo, L E Bravo, J L Realpe, R Mera.   

Abstract

OBJECTIVE: Our purpose was to find out if morphometric techniques can document long term changes in gastric antral atrophy after curing Helicobacter pylori infection with or without dietary supplementation with antioxidant micronutrients.
METHODS: Study subjects were 132 adult volunteers from a Colombian region with high gastric cancer rates. Participants were randomly assigned to ascorbic acid, beta-carotene, and anti-H. pylori treatment, following a factorial design. Gastric biopsies were obtained at baseline and after 72 months of intervention. Atrophy was evaluated by a standard visual analog scale and by morphometry.
RESULTS: Statistically significant changes in antral atrophy were detected with morphometric techniques after intervention in subjects who received anti-H. pylori treatment. A nonsignificant trend was also observed with visual scores. This effect was greater among those who were free of infection at the end of the trial. After accounting for the effect of anti-H. pylori treatment, no significant effect was noted for dietary supplementation with ascorbic acid and/or beta-carotene.
CONCLUSIONS: We conclude that gastric atrophy improves significantly after long term control of H. pylori infection. This effect can be demonstrated both by conventional histological grading and by morphometry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11774937     DOI: 10.1111/j.1572-0241.2001.05326.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

Review 1.  Biopsy assessment of drug efficacy in the gastrointestinal tract.

Authors:  Marjorie M Walker
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  Re: long term follow up of patients treated for Helicobacter pylori infection.

Authors:  Robertino Mera; Elizabeth T H Fontham; Luis E Bravo; Juan C Bravo; Maria Blanca Piazuelo; Maria Constanza Camargo; Pelayo Correa
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

Review 3.  Inflammation, atrophy, and gastric cancer.

Authors:  James G Fox; Timothy C Wang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  Gastritis staging in clinical practice: the OLGA staging system.

Authors:  Massimo Rugge; Alberto Meggio; Gianmaria Pennelli; Francesco Piscioli; Luciano Giacomelli; Giovanni De Pretis; David Y Graham
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

5.  Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.

Authors:  Bin Lu; Ming-Tao Chen; Yi-Hong Fan; Yan Liu; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 6.  Helicobacter pylori eradication for the prevention of gastric neoplasia.

Authors:  Alexander C Ford; David Forman; Richard Hunt; Yuhong Yuan; Paul Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

Review 7.  Helicobacter pylori eradication for gastric cancer prevention.

Authors:  Ting Kin Cheung; Harry H X Xia; Benjamin C Y Wong
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

8.  The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.

Authors:  Jone Garay; M Blanca Piazuelo; Sumana Majumdar; Li Li; Jimena Trillo-Tinoco; Luis Del Valle; Barbara G Schneider; Alberto G Delgado; Keith T Wilson; Pelayo Correa; Jovanny Zabaleta
Journal:  Cancer Lett       Date:  2015-11-27       Impact factor: 8.679

Review 9.  Is gastric cancer preventable?

Authors:  P Correa
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 10.  Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis.

Authors:  Yan-Jun Kong; Hong-Gang Yi; Jun-Cheng Dai; Mu-Xin Wei
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.